Análisis Argos
SCI
SCICara1 señal de riesgo
Service Corporation International · Consumer Cyclical
US$ 78.56
precio al 2026-07-04
Valor justo Argos*
US$ 51–63
vs. su valor justo
39% por encima
Score Argos
45/100
LA RESPUESTA
El mercado le pide crezca 14.4% al año — más de lo que ha demostrado (5.5%). Estás pagando un futuro que todavía no probó: el margen de error es mínimo.
Recompensas
Sin recompensas destacadas.
Riesgos
!El precio pide más crecimiento del que la empresa ha demostrado.
!Balance frágil: la deuda pesa sobre el negocio.
!Crecimiento estancado o en baja.
!Altman Z'' en zona roja (0.42)
VALOR2/6FUTURO2/6PASADO4/6SALUD1/6DIVIDENDO5/6
El Iris de calidad
VALOR2/6FUTURO2/6PASADO4/6SALUD1/6DIVIDENDO5/6
ValorCerca de su valor justo
FuturoCrecimiento moderado
PasadoFundamentales sólidos y sostenidos
SaludBalance frágil
DividendoDevuelve capital al accionista
Score Argos45de 100Cara
Ingresos3%
US$ 4.3 B
Margen operativo2%
22.6%
Flujo de caja libre2%
US$ 0.6 B
Deuda neta
US$ 4.9 B
Lo esencial, sin ruido
Cap. de mercadoUS$ 10.8B
P/E20x
EV/EBITDA12x
FCF yield5.1%
ROIC11.1%
Margen operativo22.6%
Crecim. ingresos+2.9%/año
Piotroski F7/9
Competidores

Los rivales, con el mismo ojo

El Iris de calidad de cada competidor, lado a lado. Tocá uno para ver su análisis.

Novedades

Noticias recientes

businesswire.com · 24 jun
CEL-SCI and Saudi Amarox Hold Strategic Agreement Signing Ceremony at BIO 2026, Advancing U.S.–Saudi Cooperation in Cancer Care
VIENNA, Va.--(BUSINESS WIRE)---- $CVM #BIO2026--CEL-SCI and Saudi Amarox Hold Strategic Agreement Signing Ceremony at BIO 2026, Advancing U.S.–Saudi Cooperation in Cancer Care.
businesswire.com · 16 jun
CEL-SCI Announces Closing of Offering
VIENNA, Va.--(BUSINESS WIRE)---- $CVM #Multikine--CEL-SCI announces closing of offering.
businesswire.com · 16 jun
CEL-SCI Advances Multikine® Immunotherapy for Head and Neck Cancer Through Dual U.S. Registration Study and Saudi Market Entry Strategy
VIENNA, Va.--(BUSINESS WIRE)---- $CVM #Multikine--CEL-SCI advances Multikine immunotherapy for Head and Neck Cancer through dual U.S. registration study and Saudi market entry strategy.
businesswire.com · 14 jun
CEL-SCI Corporation Announces Pricing of Offering
VIENNA, Va.--(BUSINESS WIRE)---- $CVM #Multikine--CEL-SCI Corporation announces pricing of offering.
businesswire.com · 12 jun
CEL-SCI and Saudi Amarox to Conduct Signing Ceremony at BIO 2026 for Strategic Agreement to Advance Commercialization and Distribution of Multikine® in Saudi Arabia
VIENNA, Va.--(BUSINESS WIRE)---- $CVM #Multikine--CEL-SCI and Saudi Amarox to conduct signing ceremony at BIO 2026 for Strategic Agreement to advance commercialization and distribution of Multikine.
prnewswire.com · 11 jun
SERVICE CORPORATION INTERNATIONAL INCREASES SHARE REPURCHASE AUTHORIZATION
HOUSTON, June 11, 2026 /PRNewswire/ -- Service Corporation International (NYSE: SCI), the largest provider of deathcare products and services in North America, today announced that its Board of Directors has increased the authorized level of repurchases of its common stock by approximately $472 million.  When combined with approximately $128 million of authority remaining under the existing program, this represents a total of $600 million of current share repurchase authority effective today.
seekingalpha.com · 5 jun
Dividend Champion, Contender, And Challenger Highlights: Week Of June 7
A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates.
newsfilecorp.com · 5 jun
Telescope Innovations Founder and CTO, Professor Jason Hein, Receives 2026 SCI Canada LeSueur Memorial Award
Vancouver, British Columbia--(Newsfile Corp. - June 5, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope" or the "Company") congratulates its Founder and Chief Technology Officer, Professor Jason Hein, on receiving the 2026 SCI Canada LeSueur Memorial Award from the Society of Chemical Industry ("SCI"). Figure 1. The 2026 LeSeueur Memorial Award Presented to Professor Jason Hein To view an enhanced version of this graphic, please visit: https://images.newsfilecorp.com/files/8923/300261_328197891408ab84_001full.jpg Administered by the Society of Chemical Industry, a professional body founded in London in 1881 and incorporated by Royal Charter in 1907, the LeSueur Memorial Award was established in 1955 in honour of Ernest A.

* Valor justo Argos: estimación educativa del valor intrínseco según el propio flujo de caja de la empresa y su capacidad de crecimiento — no un precio objetivo ni una recomendación. Esto es información y educación, no asesoría de inversión. Rendimiento pasado no garantiza resultados futuros.